Aimmune Therapeutics (AIMT) – Corporate News
-
Aimmune Therapeutics (AIMT) Receives $34.50/Sh Cash Tender Offer from Nestle
-
Aimmune Therapeutics (AIMT) Confirms $2B Acquisition by Nestle at $34.50/Sh
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AIMT Stock Lookup